INAUGURATION OF THE NEW GENE THERAPY PLANT OF VIRALGEN
Yesterday, June 30th, the biotechnology company Viralgen inaugurated its new facilities in the Miramón technology park (Guipúzcoa, Spain). With this plant, in which Albian Group is proud to have contributed to the design and construction, Viralgen is at the forefront...
The OEL and Safety Showers
The OEL (Occupational Exposure Limit) is an indicator that is used to prevent risks to the health of workers when handling chemical or dangerous substances. It is defined as the concentration in the air of a substance to which it is believed that workers could be...
WE PARTICIPATE AT ACHEMA PULSE!
During the month of June, Albian Group participates in the virtual event Achema Pulse, focused on new solutions in the chemical, biotechnology, pharmaceutical and food industry. The live event takes place on June 15 and 16, but its networking platform will be active...
NEW PROJECT IN SAUDI ARABIA
At Albian Group we celebrate a new achievement as we have been awarded of our first project in Saudi Arabia. The hard work of our team pays off and little by little we are present in more countries with our bespoke solutions for each client. We precisely want to...
Ingeclima, awarded at the 2021 XXI Century National Technology Awards
Yesterday, the Westin Hotel in Madrid hosted the 21st Century National Technology Awards ceremony. In this fourth edition, Ingeclima received the award in the Biotechnology category, which was collected by the CEO of Albian Group, Benigno Ferro. These awards recognize...
Albian Group and its commitment to the environment through the Tree Nation project
At Albian Group we are firmly committed to the UN Sustainable Development Goals, among which there is the goal of fighting climate change and working for the life of ecosystems. In line with this objective, our mission is to promote a responsible culture with the...
Albian Group and its commitment to the 2030 Agenda
At Albian Group we are committed to the Sustainable Development Goals of the United Nations 2030 Agenda. In order to achieve the established goals, all agents of society must contribute, and as a company we are highly committed to this project. The policies dedicated...
New Project in China
Albian Group has recently achieved a new milestone in its trajectory as we have been entrusted our first project in China. Step by step, and thanks to the efforts of the entire team, Albian Group is present in more and more countries. We would like to express our...
High Potency APIs
Advances in clinical pharmacology and cancer research are fueling the rise of high potency active pharmaceutical ingredients (HPAPIs). A significant proportion of new drugs contain HPAPIs, which is leading to a spectacular increase in demand. Manufacturing HPAPIs is a...